Puerto Rico boasts one of the most talented workforces in pharmaceutical manufacturing in the world, due to a strong university system and the long-standing history of…
When I took over the company, I understood that to survive we needed to become a global competitor. Every product and process we have needs to…
The creation of Chiesi Nordics in 2014 marked the dawn of a new era for the group in the region
One of Taiwan’s specific strengths is its clinical trial environment. Whether research is done by local players or MNCs, the quality of studies conducted in the…
We have the unique ability and responsibility, because of our location in New York, to connect [pre-IPO biotech] companies with the financial markets and to work…
Precision medicine is absolutely a growing trend in Taiwan where we see a number of high-potential opportunities
Speed is the largest [cultural] difference I have witnessed. A Chinese customer who buys a product is used to getting an answer immediately
In terms of the ASCA (Asia South and Central America) region, Taiwan is [Daiichi Sankyo's] leading market for clinical trials
Puerto Ricans are very open to participating in clinical trials and we have excellent retention rates throughout all stages of clinical trials, from phase 1 to…
Taiwan's advantages lie in our science, technology and innovation performance
The Novo Nordisk Taiwanese affiliate is rather like a high performing soccer team. I will help in giving clear direction, communication and tactics, and then results…
Eli Lilly in Puerto Rico has become a hub where local and international talents come to hone their knowledge and skills in the pharmaceutical industry, both…
See our Cookie Privacy Policy Here
